Published in J Clin Invest on June 23, 2010
Ionizing radiation: the good, the bad, and the ugly. J Invest Dermatol (2012) 1.44
Inhibition of CDK4/6 protects against radiation-induced intestinal injury in mice. J Clin Invest (2016) 1.43
NCI's provocative questions on cancer: some answers to ignite discussion. Oncotarget (2011) 1.42
A mitochondria-targeted inhibitor of cytochrome c peroxidase mitigates radiation-induced death. Nat Commun (2011) 1.09
The evolving role of radiation therapy in the management of malignant melanoma. Int J Radiat Oncol Biol Phys (2011) 1.04
TLR9 agonist protects mice from radiation-induced gastrointestinal syndrome. PLoS One (2012) 1.00
Intestinal stem cell injury and protection during cancer therapy. Transl Cancer Res (2013) 0.92
Future of radiation therapy for malignant melanoma in an era of newer, more effective biological agents. Onco Targets Ther (2011) 0.88
Wt p53 impairs response to chemotherapy: make lemonade to spare normal cells. Oncotarget (2012) 0.88
Therapeutic Targeting of CD47 to Modulate Tissue Responses to Ischemia and Radiation. J Genet Syndr Gene Ther (2011) 0.86
Mitigation of acute kidney injury by cell-cycle inhibitors that suppress both CDK4/6 and OCT2 functions. Proc Natl Acad Sci U S A (2015) 0.84
A novel radioprotective function for the mitochondrial tumor suppressor protein Fus1. Cell Death Dis (2013) 0.80
Recent progress in targeting cancer. Aging (Albany NY) (2011) 0.80
Transport processes of radiopharmaceuticals and -modulators. Radiat Oncol (2011) 0.78
Increased radiosensitivity and radiation-induced apoptosis in SRC-3 knockout mice. J Radiat Res (2013) 0.78
Role of p53 in Anticancer Drug Treatment- and Radiation-Induced Injury in Normal Small Intestine. Cancer Biol Med (2012) 0.77
Induction and inhibition of the pan-nuclear gamma-H2AX response in resting human peripheral blood lymphocytes after X-ray irradiation. Cell Death Discov (2016) 0.76
Analysis of Radiomodulatory Effect of Low-Level Laser Irradiation by Clonogenic Survival Assay. Photomed Laser Surg (2015) 0.75
Loss of LZAP inactivates p53 and regulates sensitivity of cells to DNA damage in a p53-dependent manner. Oncogenesis (2017) 0.75
Paradoxical Roles of Elongation Factor-2 Kinase in Stem Cell Survival. J Biol Chem (2016) 0.75
Activation of the Akt-CREB signaling axis by a proline-rich heptapeptide confers resistance to stress-induced cell-death and inflammation. Immunology (2017) 0.75
Nuclear factor-kappaB in cancer development and progression. Nature (2006) 18.31
Blinded by the Light: The Growing Complexity of p53. Cell (2009) 17.75
Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science (2001) 7.13
A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science (1999) 6.97
Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts. Mol Cancer Ther (2004) 5.69
An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models. Science (2008) 4.89
The pathological response to DNA damage does not contribute to p53-mediated tumour suppression. Nature (2006) 4.57
Paradoxical suppression of cellular senescence by p53. Proc Natl Acad Sci U S A (2010) 3.81
Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim Biophys Acta (2002) 3.77
Small-molecule inhibitor of p53 binding to mitochondria protects mice from gamma radiation. Nat Chem Biol (2006) 2.47
Protection against ionizing radiation by antioxidant nutrients and phytochemicals. Toxicology (2003) 2.40
Dual effect of p53 on radiation sensitivity in vivo: p53 promotes hematopoietic injury, but protects from gastro-intestinal syndrome in mice. Oncogene (2004) 2.34
Transgenic mice with p53-responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo. EMBO J (1997) 1.96
Cell kinetics and radiation biology. Int J Radiat Biol Relat Stud Phys Chem Med (1986) 1.91
Mitigation of hematologic radiation toxicity in mice through pharmacological quiescence induced by CDK4/6 inhibition. J Clin Invest (2010) 1.74
Prospective therapeutic applications of p53 inhibitors. Biochem Biophys Res Commun (2005) 1.40
Short-term injection of antiapoptotic cytokine combinations soon after lethal gamma -irradiation promotes survival. Blood (2002) 1.31
Inhibition of p53 response in tumor stroma improves efficacy of anticancer treatment by increasing antiangiogenic effects of chemotherapy and radiotherapy in mice. Cancer Res (2006) 1.23
Advances in radiotherapy for head and neck cancer. Oral Oncol (2010) 1.12
A small molecule inhibitor of p53 stimulates amplification of hematopoietic stem cells but does not promote tumor development in mice. Cell Cycle (2010) 1.01
Cyclin-dependent kinase inhibitors as potential targeted anticancer agents. Invest New Drugs (2009) 0.93
The role of p53 in determining sensitivity to radiotherapy. Nat Rev Cancer (2003) 3.89
Small-molecule inhibitor of p53 binding to mitochondria protects mice from gamma radiation. Nat Chem Biol (2006) 2.47
p53 cooperates with DNA methylation and a suicidal interferon response to maintain epigenetic silencing of repeats and noncoding RNAs. Proc Natl Acad Sci U S A (2012) 1.71
Prospective therapeutic applications of p53 inhibitors. Biochem Biophys Res Commun (2005) 1.40
Pathologies associated with the p53 response. Cold Spring Harb Perspect Biol (2010) 1.40
Inflammation and p53: A Tale of Two Stresses. Genes Cancer (2011) 1.27
Inhibition of p53 response in tumor stroma improves efficacy of anticancer treatment by increasing antiangiogenic effects of chemotherapy and radiotherapy in mice. Cancer Res (2006) 1.23
Dangerous habits of a security guard: the two faces of p53 as a drug target. Hum Mol Genet (2007) 1.04
A small molecule inhibitor of p53 stimulates amplification of hematopoietic stem cells but does not promote tumor development in mice. Cell Cycle (2010) 1.01
ATM is activated in blood monocytes after tumor radiation. Oncotarget (2013) 0.75